These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34361838)

  • 1. Detection of 4a,5-dihydropravastatin as Impurity in the Cholesterol Lowering Drug Pravastatin.
    van Scheppingen WB; Lankhorst PP; Hans M; van den Berg MA
    Molecules; 2021 Aug; 26(15):. PubMed ID: 34361838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-line extraction coupled with liquid chromatography tandem mass spectrometry for quantitation of pravastatin and its metabolite in human serum.
    Wang X; Wang Y
    Biomed Chromatogr; 2008 Jul; 22(7):719-26. PubMed ID: 18442050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
    Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, isolation and characterization of process related impurities in ezetimibe.
    Guntupalli S; Ray UK; Murali N; Gupta PB; Kumar VJ; Satheesh D; Islam A
    J Pharm Biomed Anal; 2014 Jan; 88():385-90. PubMed ID: 24176742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
    J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bile salts on gastrointestinal absorption of pravastatin.
    Chun IK; Lee KM; Lee KE; Gwak HS
    J Pharm Sci; 2012 Jul; 101(7):2281-7. PubMed ID: 22499164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of impurities in commercial spectinomycin by liquid chromatography with electrospray ionization tandem mass spectrometry.
    Wang Y; Wang M; Li J; Yao S; Xue J; Zou W; Hu C
    J Antibiot (Tokyo); 2014 Jul; 67(7):511-8. PubMed ID: 24736854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MS.
    Mulvana D; Jemal M; Pulver SC
    J Pharm Biomed Anal; 2000 Oct; 23(5):851-66. PubMed ID: 11022911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A full-scale tracing study of "ghost peaks" encountered in impurity analysis of budesonide based on experimental operation inspection-liquid chromatography/mass spectrometry fingerprint-mechanism based stress studies integrated strategy.
    Zhang L; Hu Q; Wang J; Zhang H; Han J
    J Sep Sci; 2022 Jul; 45(13):2128-2139. PubMed ID: 35396795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of pravastatin and its metabolite 3α-hydroxy pravastatin in plasma and urine of pregnant patients by LC-MS/MS.
    Zhang X; Vernikovskaya DI; Wang X; Nanovskaya TN; Costantine M; Hankins GD; Ahmed MS
    Biomed Chromatogr; 2016 Apr; 30(4):548-54. PubMed ID: 26360932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pharmaceutical impurities in formulated dosage forms.
    Pan C; Liu F; Motto M
    J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An automated method for the simultaneous determination of pravastatin and its main metabolite in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
    Kawabata K; Matsushima N; Sasahara K
    Biomed Chromatogr; 1998; 12(5):271-5. PubMed ID: 9787898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identification and chromatographic separation of a new highly analogous impurity of the active pharmaceutical ingredient icatibant.
    Lajin B; Steiner O; Fasshold L; Zangger K; Goessler W
    Eur J Pharm Sci; 2019 Apr; 132():121-124. PubMed ID: 30849486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR.
    Awasthi A; Razzak M; Al-Kassas R; Greenwood DR; Harvey J; Garg S
    Anal Bioanal Chem; 2012 Nov; 404(8):2203-22. PubMed ID: 22986987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative ion chemical ionization mass spectrometry.
    Funke PT; Ivashkiv E; Arnold ME; Cohen AI
    Biomed Environ Mass Spectrom; 1989 Oct; 18(10):904-9. PubMed ID: 2508807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a trace colored impurity in drug substance by preparative liquid chromatography and mass spectrometry.
    Wang P; Shi YJ; Helmy R; Reamer R; Vailaya A
    Rapid Commun Mass Spectrom; 2005; 19(24):3749-54. PubMed ID: 16308847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of LC-NMR and LC-MS for the separation and rapid structure elucidation of an unknown impurity in 5-aminosalicylic acid.
    Novak P; Tepes P; Fistrić I; Bratos I; Gabelica V
    J Pharm Biomed Anal; 2006 Mar; 40(5):1268-72. PubMed ID: 16253464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors.
    Kiener PA; Davis PM; Murray JL; Youssef S; Rankin BM; Kowala M
    Int Immunopharmacol; 2001 Jan; 1(1):105-18. PubMed ID: 11367508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.